Publications en collaboration avec des chercheurs de Instituto de Salud Carlos III (25)

2024

  1. COPD: systemic proteomic profiles in frequent and infrequent exacerbators

    ERJ Open Research, Vol. 10, Núm. 2

  2. Epicardial and liver fat implications in albuminuria: a retrospective study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

2023

  1. Evaluation of Microvascular Rarefaction in Vascular Cognitive Impairment and Heart Failure (CRUCIAL): Study Protocol for an Observational Study

    Cerebrovascular Diseases Extra, Vol. 13, Núm. 1, pp. 18-32

  2. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document

    Revista Espanola de Cardiologia, Vol. 76, Núm. 3, pp. 183-196

  3. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document

    Radiologia, Vol. 65, Núm. 3, pp. 269-284

2022

  1. Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy

    Cancer research, Vol. 82, Núm. 23, pp. 4373-4385

  2. Liver transplantation for subacute hepatic necrosis and rapid liver failure following bariatric surgery

    ANZ Journal of Surgery

  3. Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies

    Cancers, Vol. 13, Núm. 12

  2. Challenges and novel opportunities of radiation therapy for brain metastases in non-small cell lung cancer

    Cancers, Vol. 13, Núm. 9

  3. Circulating levels of the interferon-γ-regulated chemokines cxcl10/cxcl11, il-6 and hgf predict outcome in metastatic renal cell carcinoma patients treated with antiangiogenic therapy

    Cancers, Vol. 13, Núm. 11

  4. Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy

    Cancer Letters, Vol. 499, pp. 279-289

  5. SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3

2020

  1. Epigenetic SmAd3 repression in tumor-associated fibroblasts impairs fibrosis and response to the antifibrotic drug nintedanib in lung squamous cell carcinoma

    Cancer Research, Vol. 80, Núm. 2, pp. 276-290

  2. Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors

    Annals of Oncology, Vol. 31, Núm. 2, pp. 274-282

  3. Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: Preliminary experience from a series of 10 Spanish patients

    Thorax, Vol. 75, Núm. 12, pp. 1116-1118

  4. Severe colon ischemia in patients with severe coronavirus-19 (COVID-19)

    Revista Española de Enfermedades Digestivas, Vol. 112, Núm. 10, pp. 784 - 787

2019

  1. Emphysema phenotypes and lung cancer risk

    PLoS ONE, Vol. 14, Núm. 7

  2. The differential impact of SRC expression on the prognosis of patients with head and neck squamous cell carcinoma

    Cancers, Vol. 11, Núm. 11

2018

  1. Comparison of RNA-seq and microarray platforms for splice event detection using a cross-platform algorithm

    BMC Genomics, Vol. 19, Núm. 1